W7L.L

Warpaint London Plc
Warpaint London PLC - PDMR/PCA Dealing
15th July 2024, 09:15
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 4075W
Warpaint London PLC
15 July 2024
 

15 July 2024

Warpaint London PLC

("Warpaint", the "Company" or the "Group")

PDMR/PCA Dealing

Warpaint London plc (AIM: W7L; OTCQX: WPNTF), the specialist supplier of colour cosmetics and owner of the W7 and Technic brands, announces the following transactions in the Company's ordinary shares by a PDMR/PCA which occurred on 11 and 12 July 2024.

The information in the below notification is disclosed in accordance with Article 19 of the EU Market Abuse Regulation.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Joe Sadler

2

Reason for the notification

a)

Position/status

PCA of Keith Sadler, PDMR - Non-executive Director

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Warpaint London PLC

b)

LEI

213800EBJ2CN6KIDCO78

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 25p each

 

 

GB00BYMF3676

b)

Nature of the transaction

Sale of Shares

c)

Price(s) and volume(s)

  Price(s)

Volume(s)

611p

5,000

595p

11,950

 

d)

Aggregated information

- Aggregated volume

- Price


N/A - single transaction

N/A - single transaction

e)

Date of the transaction

11 July 2024

12 July 2024

f)

Place of the transaction

AIM, London Stock Exchange

 

 

 

Enquiries:


Warpaint London plc

c/o IFC

Sam Bazini - Chief Executive Officer

Eoin Macleod - Managing Director

Neil Rodol - Chief Financial Officer

 

 

 

 

Shore Capital (Nominated Adviser & Broker)

 

+44 (0)20 7408 4090

Patrick Castle, Daniel Bush - Corporate Advisory

Fiona Conroy - Corporate Broking


 


IFC Advisory (Financial PR & IR)

Tim Metcalfe, Graham Herring, Florence Chandler

+44 (0)20 3934 6630

 

Warpaint London plc

 

Warpaint sells branded cosmetics under the lead brand names of W7 and Technic. W7 is sold in the UK primarily to major retailers and internationally to local distributors or retail chains. The Technic brand is sold in the UK and continental Europe with a significant focus on the gifting market, principally for high street retailers and supermarkets.  In addition, Warpaint supplies cosmetics under its other brand names of Man'stuff, Body Collection and Chit Chat, each targeting a different demographic.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKELBFZDLFBBZ]]>
TwitterFacebookLinkedIn